Coming In Thursday's 'The Pink Sheet' DAILY - FDA User Fee Bill Moves Through House
House is expected to pass FDA user fee bill - Regeneron and Sanofi plan to begin a Phase III trial of their PCSK9 inhibitor for hypercholesterolemia - FDA panel to review GlaxoSmithKline's supplemental application for use of Tykerb in combination with Herceptin in women who failed on Herceptin alone read more..
No comments:
Post a Comment